These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 15480722

  • 1. The feasibility and morbidity of distal pancreatectomy in extensive cytoreductive surgery for advanced epithelial ovarian cancer.
    Yildirim Y, Sanci M.
    Arch Gynecol Obstet; 2005 Jun; 272(1):31-4. PubMed ID: 15480722
    [Abstract] [Full Text] [Related]

  • 2. Central pancreatectomy: single-center experience of 50 cases.
    Adham M, Giunippero A, Hervieu V, Courbière M, Partensky C.
    Arch Surg; 2008 Feb; 143(2):175-80; discussion 180-1. PubMed ID: 18283143
    [Abstract] [Full Text] [Related]

  • 3. Secondary cytoreductive surgery for isolated nodal recurrence in patients with epithelial ovarian cancer.
    Santillan A, Karam AK, Li AJ, Giuntoli R, Gardner GJ, Cass I, Karlan BY, Bristow RE.
    Gynecol Oncol; 2007 Mar; 104(3):686-90. PubMed ID: 17141302
    [Abstract] [Full Text] [Related]

  • 4. The benefits of low anterior en bloc resection as part of cytoreductive surgery for advanced primary and recurrent epithelial ovarian cancer patients outweigh morbidity concerns.
    Park JY, Seo SS, Kang S, Lee KB, Lim SY, Choi HS, Park SY.
    Gynecol Oncol; 2006 Dec; 103(3):977-84. PubMed ID: 16837030
    [Abstract] [Full Text] [Related]

  • 5. What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?
    Chi DS, Eisenhauer EL, Lang J, Huh J, Haddad L, Abu-Rustum NR, Sonoda Y, Levine DA, Hensley M, Barakat RR.
    Gynecol Oncol; 2006 Nov; 103(2):559-64. PubMed ID: 16714056
    [Abstract] [Full Text] [Related]

  • 6. Aggressive surgical strategies in advanced ovarian cancer: a monocentric study of 203 stage IIIC and IV patients.
    Colombo PE, Mourregot A, Fabbro M, Gutowski M, Saint-Aubert B, Quenet F, Gourgou S, Rouanet P.
    Eur J Surg Oncol; 2009 Feb; 35(2):135-43. PubMed ID: 18289825
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [How to increase the optimal rate of secondary cytoreductive surgery in recurrent epithelial ovarian cancer].
    Li YF, Li MD, Liu FY, Liu JH, Li JD.
    Ai Zheng; 2003 Nov; 22(11):1193-6. PubMed ID: 14613651
    [Abstract] [Full Text] [Related]

  • 11. Cytoreductive surgery and modified heated intraoperative intraperitoneal chemotherapy (HIPEC) for advanced and recurrent ovarian cancer -- 12-year single center experience.
    Pavlov MJ, Kovacevic PA, Ceranic MS, Stamenkovic AB, Ivanovic AM, Kecmanovic DM.
    Eur J Surg Oncol; 2009 Nov; 35(11):1186-91. PubMed ID: 19356887
    [Abstract] [Full Text] [Related]

  • 12. Bowel resection at the time of primary debulking for epithelial ovarian carcinoma: outcomes in patients treated with platinum and taxane-based chemotherapy.
    Estes JM, Leath CA, Straughn JM, Rocconi RP, Kirby TO, Huh WK, Barnes MN.
    J Am Coll Surg; 2006 Oct; 203(4):527-32. PubMed ID: 17000397
    [Abstract] [Full Text] [Related]

  • 13. Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study.
    Winter WE, Maxwell GL, Tian C, Sundborg MJ, Rose GS, Rose PG, Rubin SC, Muggia F, McGuire WP, Gynecologic Oncology Group.
    J Clin Oncol; 2008 Jan 01; 26(1):83-9. PubMed ID: 18025437
    [Abstract] [Full Text] [Related]

  • 14. En bloc vascular resection for locally advanced pancreatic malignancies infiltrating major blood vessels: perioperative outcome and long-term survival in 136 patients.
    Yekebas EF, Bogoevski D, Cataldegirmen G, Kunze C, Marx A, Vashist YK, Schurr PG, Liebl L, Thieltges S, Gawad KA, Schneider C, Izbicki JR.
    Ann Surg; 2008 Feb 01; 247(2):300-9. PubMed ID: 18216537
    [Abstract] [Full Text] [Related]

  • 15. Distal pancreatectomy--does it have a role for pancreatic body and tail cancer.
    Kayahara M, Nagakawa T, Ueno K, Ohta T, Kitagawa H, Arakawa H, Yagi H, Tajima H, Miwa K.
    Hepatogastroenterology; 1998 Feb 01; 45(21):827-32. PubMed ID: 9684142
    [Abstract] [Full Text] [Related]

  • 16. Perioperative morbidity and outcome of secondary cytoreduction for recurrent epithelial ovarian cancer.
    Woelber L, Jung S, Eulenburg C, Mueller V, Schwarz J, Jaenicke F, Mahner S.
    Eur J Surg Oncol; 2010 Jun 01; 36(6):583-8. PubMed ID: 20488646
    [Abstract] [Full Text] [Related]

  • 17. The incidence of major complications after the performance of extensive upper abdominal surgical procedures during primary cytoreduction of advanced ovarian, tubal, and peritoneal carcinomas.
    Chi DS, Zivanovic O, Levinson KL, Kolev V, Huh J, Dottino J, Gardner GJ, Leitao MM, Levine DA, Sonoda Y, Abu-Rustum NR, Brown CL, Barakat RR.
    Gynecol Oncol; 2010 Oct 01; 119(1):38-42. PubMed ID: 20609464
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer.
    Eisenhauer EL, Abu-Rustum NR, Sonoda Y, Levine DA, Poynor EA, Aghajanian C, Jarnagin WR, DeMatteo RP, D'Angelica MI, Barakat RR, Chi DS.
    Gynecol Oncol; 2006 Dec 01; 103(3):1083-90. PubMed ID: 16890277
    [Abstract] [Full Text] [Related]

  • 20. Distal pancreatectomy with splenectomy for the management of splenic hilum metastasis in cytoreductive surgery of epithelial ovarian cancer.
    Xiang L, Tu Y, He T, Shen X, Li Z, Wu X, Yang H.
    J Gynecol Oncol; 2016 Nov 01; 27(6):e62. PubMed ID: 27550408
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.